Guideline for the management of diseases caused by non-tuberculous mycobacteria

Chairs: C. Lange & J. Van Ingen

Nontuberculous mycobacteria (NTM) represent over 160 species which vary greatly in their prevalence, pathogenicity, in vitro drug resistance, and response to therapy. Recent studies have documented high and increasing annual prevalences of pulmonary NTM infections in several regions of the world.

Pulmonologists and infectious diseases physicians are currently much more likely to encounter NTM infections than tuberculosis. Development of new NTM guidelines are therefore necessary not only to update the previous guidelines with the profusion of new information about NTM disease that has become available since publication of the last guidelines but to reinvigorate the education effort about NTM disease and to promote the universal adoption of evidence-based treatment strategies for NTM.

This project is jointly handled by the ERS, ATS, ISDA and ESCMID.